Director

• Champion institutional advocacy for the adoption of the Radioligand Therapies (RLT) and Neuroendocrine Tumors (NET) brand to support appropriate product utilization.
• Build strong partnerships with Neuroendocrine Tumors Centers of Excellence and health care system sites to drive impactful engagement.
• Develop, coordinate, and execute strategic business plans for priority accounts, ensuring alignment with market dynamics and organizational goals.
• Cultivate relationships with clinical, operational, and administrative decision-makers to streamline care pathways, treatment protocols, and workflow solutions.
• Stay informed on market trends, customer economics, and access models, including payment programs and reimbursement strategies.
• Share knowledge of Novartis’ offerings and ensure account administrators have access to relevant resources, while maintaining compliance.
• Collaborate with local teams to create tailored, institution-specific plans that reflect local market forces and opportunities.
• Deliver approved product and disease state presentations to clinicians and staff, fostering trust and collaboration across key partners.
• Conduct periodic needs assessments to identify opportunities and communicate actionable insights to cross-functional partners.
• Support team members in diagnosing business challenges and implementing strategies that optimize outcomes for Radioligand Therapies and Neuroendocrine Tumors accounts and affiliated health systems.

Associate Director, Radioligand Therapies – Priority Accounts

Senior Director, Integrated Systems

Field Access Director – Rare Disease

Executive Underwriter, AVP – Underwriting Director, Contract Surety

Associate Director, Radioligand Therapies – Priority Accounts